What A New Antiviral Drug Could Mean For The Future Of COVID

An advisory panel to the U.S. Food and Drug Administration advisory panel has voted to recommend that the FDA approve a new antiviral drug to treat COVID-19. The FDA decision is expected soon. Host Emily Kwong chats with health reporter Pien Huang on the state of treatments and how this drug and other treatment options may change the pandemic.

For more of Pien's reporting, check out "New antiviral drugs are coming for COVID. Here's what you need to know." <>

You can follow Emily on Twitter @EmilyKwong1234 and Pien @Pien_Huang. Email Short Wave at [email protected].

To manage podcast ad preferences, review the links below:

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy